Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125692241 | 12569224 | 1 | I | 20160429 | 20160714 | 20160719 | 20160719 | EXP | BE-ROCHE-1797049 | ROCHE | 79.54 | YR | M | Y | 0.00000 | 20160719 | MD | BE | BE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125692241 | 12569224 | 1 | PS | Ranibizumab | RANIBIZUMAB | 1 | Other | 0.5 MG, UNK | Y | 125156 | .5 | MG | SOLUTION FOR INJECTION | ||||||
125692241 | 12569224 | 2 | SS | Ranibizumab | RANIBIZUMAB | 1 | Other | 0.5 MG, UNK | Y | 125156 | .5 | MG | |||||||
125692241 | 12569224 | 3 | C | ASAFLOW | ASPIRIN | 1 | Unknown | 80 MG, QD | U | 0 | 80 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125692241 | 12569224 | 1 | Retinal vein occlusion |
125692241 | 12569224 | 3 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125692241 | 12569224 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125692241 | 12569224 | Cerebrovascular accident |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125692241 | 12569224 | 1 | 20150319 | 0 | ||
125692241 | 12569224 | 2 | 20160428 | 20160428 | 0 |